CA-ENVIRO-DEFENSE-FUND
5.3.2024 03:38:29 CET | Business Wire | Press release
Just after 4:00pm Pacific Time today MethaneSAT effectively detached from SpaceX Transporter-10 that carried the emissions monitor into space. The groundbreaking satellite is designed to help protect the Earth’s climate by accelerating reductions of a powerful greenhouse pollutant, focusing first on oil and gas operations, a major source of methane.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240304322966/en/
MethaneSAT (Photo: Business Wire)
A digital media kit with photos, videos and graphics is available HERE.
Developed by a subsidiary of the global non-profit Environmental Defense Fund, MethaneSAT will see and quantify total methane emissions over wide areas that other satellites can’t and identify large emitters in places they aren’t looking. Data from MethaneSAT will enable both companies and regulators to track emissions, and give stakeholders – citizens, governments and investors – free, near-real time access to the data, and the unprecedented ability to compare the results against emission goals and obligations.
“Cutting methane pollution from fossil fuel operations, agriculture and other sectors is the single fastest way to slow the rate of warming as we continue to decarbonize our energy systems,” said EDF President Fred Krupp. “To do that requires comprehensive data on this pollution on a global scale. MethaneSAT will show us the full scope of the opportunity by tracking emissions to their source.”
Krupp announced MethaneSAT in a 2018 TED Talk as part of the TED Audacious Project. EDF has been a global leader in methane science and solutions for more than a decade, putting the problem on the map by organizing a pioneering series of 16 independent studies that showed methane emissions across the U.S. oil and gas supply chain were 60% higher than EPA estimates at the time. MethaneSAT is a direct outgrowth of these efforts.
“MethaneSAT’s superpower is the ability to precisely measure methane levels with high resolution over wide areas, including smaller, diffuse sources that account for most emissions in many regions,” said Steven Hamburg, EDF Chief Scientist and MethaneSAT project leader. “Knowing how much methane is coming from where and how the rates are changing is essential.”
Circling the Earth 15 times a day, MethaneSAT will measure changes in methane concentrations as small as three parts per billion. High sensitivity together with high resolution and a wide field of view will enable MethaneSAT to see the whole emissions picture (see more detail here).
These unique capabilities usher in a new era of transparency for the industry. Interactive emissions data will be available to anyone directly from www.MethaneSAT.org and on Google Earth Engine, a premier geospatial data platform used by over 100,000 experts and analysts.
MethaneSAT was made possible entirely by the support of EDF donors and our partnership with the Government of New Zealand. Among the largest contributors to MethaneSAT are the Bezos Earth Fund, Arnold Ventures, the Robertson Foundation and the TED Audacious Project.
“Methane emissions have been overlooked and hard to detect for far too long,” said Dr. Kelly Levin, Chief of Science, Data and Systems Change at the Bezos Earth Fund. “MethaneSAT changes the equation, putting science and data front and center. From the sky, it can see what others can’t, helping good actors and holding bad actors accountable. The Bezos Earth Fund is proud to be a partner in this adventure.”
In December, EDF joined with Bloomberg Philanthropies, the International Energy Agency, RMI and the UN Environment Programme’s International Methane Emission Observatory on a new, first-of-its-kind initiative to hold companies and governments more accountable for their methane management.
“You can’t manage what you can’t measure, and that’s certainly true when it comes to cutting methane, one of the biggest drivers of climate change,” said Michael R. Bloomberg, UN Secretary-General's Special Envoy on Climate Ambition and Solutions and Founder of Bloomberg LP and Bloomberg Philanthropies. “Data from this satellite will help us to better measure methane emissions and target their sources, bringing more transparency to the problem, giving companies and investors the information they need to take action, and empowering the public to hold people accountable.”
In addition to identifying emission sources and rates for a given region, MethaneSAT will make it possible to compare emission loss rates across major oil and gas regions worldwide and performance over time. Analytics developed specially for the mission will trace those emissions back to their sources within those target regions.
“We have consistently seen the power of strong data to win robust regulatory safeguards and better operating practices in the industry. Good science lays the groundwork for better decisions,” said Mark Brownstein, EDF Senior Vice President, Energy Transition.
In January the Biden Administration proposed rules for a fee on excess methane emissions, which will require accurate emissions reporting. European legislation agreed to in November charts a pathway toward requiring empirical emissions data from gas importers, while Japan and Korea – two of the largest LNG buyers – have launched plans to begin requiring emissions data from suppliers.
As methane standards are incorporated into national policy and trade agreements, MethaneSAT will help ensure targets are being met, and make clear where claimed reductions fall short.
Over 150 countries have signed the Global Methane Pledge to cut their collective methane emissions at least 30 percent from 2020 levels by 2030. At COP 28, over 50 companies announced the Oil & Gas Decarbonization Charter, committing to virtually eliminate methane emissions and routine flaring.
In addition to parent organization EDF, MethaneSAT partners include Harvard University’s School of Engineering and Applied Sciences, the Smithsonian Astrophysical Observatory, and the New Zealand Space Agency. The combined mission team has over 70 experts worldwide with experience in spaceflight, remote sensing, and data analytics.
The satellite was built in Colorado by the Space & Mission Systems unit of BAE Systems, Inc. (formerly Ball Aerospace) and Blue Canyon Technologies.
MethaneSAT, LLC is a subsidiary of Environmental Defense Fund, Incorporated, a leading international nonprofit organization. EDF links science, economics, law, and innovative private-sector partnerships to create transformational solutions to the most serious environmental problems. Follow us on Twitter at @MethaneSAT, or connect with us at www.MethaneSat.org. Copyright © 2024 MethaneSAT, LLC. All Rights Reserved.
One of the world's leading international nonprofit organizations, Environmental Defense Fund (edf.org) creates transformational solutions to the most serious environmental problems. To do so, EDF links science, economics, law, and innovative private-sector partnerships. With more than 3 million members and offices in the United States, China, Mexico, Indonesia and the European Union, EDF’s scientists, economists, attorneys and policy experts are working in 28 countries to turn our solutions into action. Connect with us on Twitter @EnvDefenseFund.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240304322966/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
